P898: COMPARISON OF TECLISTAMAB WITH BELANTAMAB MAFODOTIN IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA USING MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON. (23rd June 2022) - Delforge, M.; Usmani, S. Z.; van de Donk, N. W.; Garfall, A. L.; Moreau, P.; Oriol, A.; Nooka, A. K.; Rosinol, L.; Bahlis, N.; Rodriguez-Otero, P.; Martin, T.; Diels, J.; et al.